These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 39119234)

  • 21. Induction of Apoptosis in Lung Cancer Cells by Viburnum grandiflorum via Mitochondrial Pathway.
    Han B; Wu J; Huang L
    Med Sci Monit; 2020 Jan; 26():e920265. PubMed ID: 31900380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RHBDD1 silencing inhibited cell growth and invasion of non-small cell lung cancer by mediating ZEB1/PI3K/AKT signaling pathway.
    Xu Z; Wang R; Li X; Yang L; Peng H; Wang Y; Wang P
    J Mol Histol; 2021 Jun; 52(3):503-510. PubMed ID: 33515112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of lncRNA LSAT1 in the invasion and metastasis of non-small cell lung cancer under hypoxia.
    Zhang L; Wan ZY; Zhang X; Liu J; Huang WY; Zhao YB
    Transl Cancer Res; 2020 Feb; 9(2):1125-1132. PubMed ID: 35117456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The CK2 inhibitor quninalizarin enhances the anti-proliferative effect of icotinib on EGFR-TKIs-resistant cell lines and its underlying mechanisms].
    Zhou Y; Zhang S; Li K; Li QW; Zhou FZ; Li ZY; Ma H; Dong XR; Liu L; Wu G; Meng R
    Zhonghua Zhong Liu Za Zhi; 2016 Feb; 38(2):100-4. PubMed ID: 26899328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and invasion by inhibiting G9a in non-small-cell lung cancer A549 cells.
    Zhang L; Liang B; Xu H; Gong Y; Hu W; Jin Z; Wu X; Chen X; Li M; Shi L; Shi Y; Wang Y; Yang L
    J Ethnopharmacol; 2022 Jun; 291():115095. PubMed ID: 35176466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erlotinib induces the human non-small-cell lung cancer cells apoptosis via activating ROS-dependent JNK pathways.
    Shan F; Shao Z; Jiang S; Cheng Z
    Cancer Med; 2016 Nov; 5(11):3166-3175. PubMed ID: 27726288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phanginin R Induces Cytoprotective Autophagy via JNK/c-Jun Signaling Pathway in Non-Small Cell Lung Cancer A549 Cells.
    Zhang LL; Bao H; Xu YL; Jiang XM; Li W; Zou L; Lin LG; Lu JJ
    Anticancer Agents Med Chem; 2020; 20(8):982-988. PubMed ID: 32286950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GPX3 represses pancreatic cancer cell proliferation, migration and invasion, and improves their chemo‑sensitivity by regulating the JNK/c‑Jun signaling pathway.
    Ma Y; Zhang L; Gao X; Zhu D
    Exp Ther Med; 2024 Mar; 27(3):118. PubMed ID: 38361519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of Krüppel-Like Factor 4 Suppresses Migration and Invasion of Non-Small Cell Lung Cancer Through c-Jun-NH2-Terminal Kinase/Epithelial-Mesenchymal Transition Signaling Pathway.
    Wu Y; Lin L; Wang X; Li Y; Liu Z; Ye W; Huang W; Lin G; Liu H; Zhang J; Li T; Zhao B; Lv L; Li J; Wang N; Liu X
    Front Pharmacol; 2019; 10():1512. PubMed ID: 31969824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of NADPH homeostasis by total flavonoids from Adinandra nitida Merr. ex Li leaves triggers ROS-dependent p53 activation leading to apoptosis in non-small cell lung cancer cells.
    Lan T; He S; Luo X; Pi Z; Lai W; Jiang C; Gan J; Wei S; Wu Z; Yun C; Leng J; Li C
    J Ethnopharmacol; 2024 Oct; 332():118340. PubMed ID: 38762212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MALT1 promotes melanoma progression through JNK/c-Jun signaling.
    Wang Y; Zhang G; Jin J; Degan S; Tameze Y; Zhang JY
    Oncogenesis; 2017 Jul; 6(7):e365. PubMed ID: 28759024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M; Zhou LY; Xu N; An Q
    Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.
    Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X
    Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone morphogenetic protein-9 promotes the proliferation of non-small cell lung cancer cells by activating PI3K/Akt and Smad1/5 pathways.
    Hou X; Peng Y; Liu J; Zhong Q; Yu Z; Zhang L
    RSC Adv; 2020 Feb; 10(12):7214-7220. PubMed ID: 35493870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of mdig on proliferation and apoptosis of lung cancer cells.
    Xu X; Cao L; Zhang Y; Lian H; Sun Z; Cui Y
    Oncol Lett; 2018 Dec; 16(6):7146-7151. PubMed ID: 30546450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-92b inhibits proliferation and invasion of lung cancer by targeting EZH2.
    Chen L; Zhuo HZ; Wu JY; Lin LY; Huang ZL; Lu JX; Cheng KL
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3166-3173. PubMed ID: 32271434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
    Xue D; Yang P; Wei Q; Li X; Lin L; Lin T
    Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2/STAT3 pathway in non-small cell lung cancer.
    Wei L; Liu Y; Ma Y; Ding C; Zhang H; Lu Z; Gu Z; Zhu C
    Cell Cycle; 2019 Dec; 18(24):3456-3471. PubMed ID: 31731888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells.
    Feng X; Liu H; Zhang Z; Gu Y; Qiu H; He Z
    J Exp Clin Cancer Res; 2017 Sep; 36(1):123. PubMed ID: 28886730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.